Posted on
Share on Facebook
Share on Twitter
Share on LinkedIn

Healthcare conglomerate Johnson & Johnson said on Monday the U.S. Justice Department has opened an investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that bought two of its drugs.

Read More